Inhibition of hypothalamic fractalkine (CX3CL1) reduces diet-induced hypothalamic inflammation and recruitment of BM monocytic cells to the hypothalamus, reduces obesity, and protects against glucose intolerance [123]. This evidence concerns the gene CX3CL1 and obesity due to melanocortin 4 receptor deficiency.